Literature DB >> 24557626

MSI/LOH and extron expression of the FHIT gene in gastric carcinoma.

Yuping Xiao1, Lili Mao, Chengbo Han, Jinyi Li, Lei Xu, Yan Xin.   

Abstract

We detected loss of heterozygosity (LOH) and microsatellite instabilities (MSI), as well as extron expression of the fragile histidine triad (FHIT) gene in gastric carcinoma (GC), in order to evaluate their association with clinicopathological processes in gastric carcinogenesis. LOH and MSI of the FHIT were detected by using PCR at 4 microsatellite loci: D3S 1300, D3S 4103, D3S 1481, D3S 1234 in cancer tissues from 50 patients with primary GC, with normal mucosa acting as matched controls. FHIT transcripts were detected by nested RT-PCR in 30 cases of GC and their products were sequenced. Results show that the average frequencies of LOH and MSI of the FHIT gene in GC were 32.4% and 26.4%, respectively. There was no correlation between LOH and MSI of the FHIT gene in GC and the histological characteristics of gastric carcinoma (Bormann's or Lauren's classification). LOH of the FHIT gene in GC was related to depth invasiveness, and its frequency in GC where serosa was penetrated was significantly higher than that in GC without serosa penetration (73.5% vs 37.5%, P < 0.05). The frequency of MSI in GC without lymph node metastasis was significantly higher than that in GC with lymph node metastasis (66.7% vs 34.3%, P < 0.05). Aberrant transcripts were found in 11/30 GC tissues. Sequencing analysis of the aberrant fragments found a RT-PCR product missing exons 5-7 in one case of GC, and another product missing exons 4-7. Four of 10 (40.0%) cases of primary GC showed absent or decreased expression of the FHIT protein as compared to their matched normal tissues. The findings in this study suggest that LOH and MSI of FHIT gene may induce aberrant extron expression, which might play a role in gastric carcinogenesis.

Entities:  

Year:  2007        PMID: 24557626     DOI: 10.1007/s11684-007-0019-1

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  14 in total

1.  Loss of Fhit protein in carcinoma of primary and secondary müllerian systems.

Authors:  M R Quddus; C J Sung; S W Cook; C Wang; M M Steinhoff; K Hansen
Journal:  Histopathology       Date:  2004-01       Impact factor: 5.087

2.  High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.

Authors:  C Huiping; S Kristjansdottir; J T Bergthorsson; J G Jonasson; J Magnusson; V Egilsson; S Ingvarsson
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

3.  Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.

Authors:  Jenq-Yuh Ko; Tso-Ching Lee; Chin-Fu Hsiao; Guan-Lu Lin; Sang-Hue Yen; Kuang Y Chen; Chao A Hsiung; Pei-Jer Chen; Mow-Ming Hsu; Yuh-Shan Jou
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

4.  Ets1 as a marker of malignant potential in gastric carcinoma.

Authors:  Yong Yu; Yi-Chu Zhang; Wen-Zhu Zhang; Li-Song Shen; Paul Hertzog; Trevor J Wilson; Da-Kang Xu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  [Quantitation and detection of deletion in tumor mitochondrial DNA by microarray technique].

Authors:  Cheng-bo Han; Yu-jie Zhao; Fan Li; Qun He; Jia-ming Ma; Yan Xin
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2004-01

6.  Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.

Authors:  Ignacio I Wistuba; Raheela Ashfaq; Anirban Maitra; Hector Alvarez; Erick Riquelme; Adi F Gazdar
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

7.  Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.

Authors:  Farkas Sükösd; Naoto Kuroda; Tamas Beothe; Amrit Pal Kaur; Gyula Kovacs
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

8.  [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].

Authors:  Cheng-Cai Yao; Cong-Yao Lin; Ming-Bo Hu
Journal:  Ai Zheng       Date:  2004-03

9.  Loss of fragile histidine triad protein in human hepatocellular carcinoma.

Authors:  Po Zhao; Xin Song; Yuan-Yuan Nin; Ya-Li Lu; Xiang-Hong Li
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

10.  Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.

Authors:  H Andachi; K Yashima; M Koda; K Kawaguchi; A Kitamura; A Hosoda; Y Kishimoto; G Shiota; H Ito; M Makino; N Kaibara; H Kawasaki; Y Murawaki
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

View more
  3 in total

1.  Parkin gene alterations in ovarian carcinoma from northern Indian population.

Authors:  Syed Jafar Mehdi; Asgar Ali; M Moshahid Alam Rizvi
Journal:  Pathol Oncol Res       Date:  2011-01-10       Impact factor: 3.201

2.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

3.  Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population.

Authors:  M Moshahid Alam Rizvi; M Shabbir Alam; Syed Jafar Mehdi; Asgar Ali; Swaraj Batra
Journal:  Pathol Oncol Res       Date:  2011-09-08       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.